🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to utilize in-vivo confocal microscopy to desc...
Status
Completed
Location
University of Iowa
Start Date
2010-08
Trial ID
NCT01250925
Treatments Being Tested
The purpose of this study was to investigate contact lens fit, lens paramet...
Status
Completed
Location
Alcon Call Center for Trial Locations
Start Date
2008-11
Trial ID
NCT00799422
Treatments Being Tested
The purpose of this study is to compare the performance of two commercially...
Status
Completed
Location
Multiple Locations
Start Date
2011-02
Trial ID
NCT01300741
The purpose of this study was to assess and compare the effect of the repea...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01594294
The purpose of this study is to compare two marketed contact lens care solu...
Status
Completed
Location
Multiple Locations
Start Date
2008-09-01
Trial ID
NCT00813761
The purpose of this study is to evaluate CLEAR CARE® PLUS (CCP) compared to...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-13
Trial ID
NCT02965833
The purpose of this study is to evaluate on-eye clinical performance of the...
Status
Completed
Location
Dr.Elsa Pao, O.D
Start Date
2024-07-26
Trial ID
NCT06461455
The purpose of this study is to evaluate worn AIR OPTIX® plus HYDRAGLYDE® (...
Status
Completed
Location
Alcon Investigative Site
Start Date
2017-02-13
Trial ID
NCT03026257
Treatments Being Tested
The purpose of this study is demonstrate substantial equivalence of an inve...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01912781
Crossover clinical evaluation three contact lens care regimens used for one...
Status
Completed
Location
Centre for Contact Lens Research
Start Date
2011-02
Trial ID
NCT01294917
Treatments Being Tested